Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2023
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- COVID-19 (MeSH)
- Humans (MeSH)
- Immunologic Factors (MeSH)
- Microbiology (Science Metrix)
- SARS-CoV-2 (MeSH)
- Treatment Outcome (MeSH)